App-Quantinova.ai

T-cell Subset Analysis in IgG4-Related Disease and Lymphocyte-variant Hypereosinophilic Syndrome

Bakul Dalal - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Hypereosinophilic Syndrome

N/A

From Plague to Pets: A Case of Rate-bite Fever

Michael E. Schachter - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Infectious arthritis

Penicillin

Assessment of the Temporal Variation of the Fibromyalgia Patient Profile between 2005 and 2013: Do Guidelines Inform Clinical Care?

Emmanouil Rampakakis - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Fibromyalgia

N/A

Audit and Feedback of Patient Reported Outcomes in Knee Osteoarthritis to Improve Management in Primary Care: A Pilot Project

Roni Propp - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

A Randomized, Double-blind, Active- and Placebo-controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naive to Biologic Disease Modifying Antirheumatic Drugs with Active Psoriatic Arthritis

Desiree Van der Heijde - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriatic arthritis

Adalimumab

Prevalence and Factors Associated with Non-traumatic Vertebral Fractures in Psoriatic Arthritis

Sindhu Johnson - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

Methotrexate

Ribbings Disease Compared to Intramedullary Osteosclerosis: A Case Presentation

Arthur Lau - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Bone infection

Lansoprazole

Assessing Gout Quality Indicators in Electronic Medical Records: A Feasibility Study

Nicole Tsao - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Renal insufficiency

N/A

Development and Testing of an On-line Technology Tool to Facilitate Tracking of Data and Analyzing Outcomes in Inflammatory Arthritis across Multiple Practices

Carolyn Neville - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

The Early Arthritis Screening and Treatment (EAST) Program for Eastern Quebec Improves Inflammatory Arthritis Care.

Alexandra Godbout - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

A Longitudinal Analysis of Change in Lupus Nephritis in an International Inception Cohort using a Multistate Markov Model Approach

John Hanly - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus nephritis

N/A

Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-term (104- Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III, Randomized, Controlled Trials

Arthur Kavanaugh - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

Apremilast

Rheumatoid Arthritis Disease Trackers to Support Treat to Target Strategies: A Needs Assessment Survey

Majed Khraishi - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Patients who Fail to Achieve Minimal Disease Activity (MDA): What is Done? An Analysis from a Prospective, Observational Registry

Proton Rahman - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Development of an SI Joint CT Screening Tool for the Identification of Axial Spondylitis

Ismail Sari - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Psoriasis

N/A

MakeRheum for Rheumatology: Testing Novel Ways to Increase Interest in Rheumatology by Canadian Undergraduate and Postgraduate Medical Trainees Kimberly Legault (McMaster University, Hamilton); Volodko Bakowsky (Dalhousie, Halifax);

Elizabeth Hazel - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Comparison of Dose Escalation and Co-therapy Intensification between Patients with Rheumatoid Arthritis Initiating Biologic Treatment with Etanercept, Adalimumab and Infliximab

Gilles Boire - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Adalimumab

Internal Medicine Resident Knowledge and Perceptions about Rheumatology Results from the MSQuebec Workshop

Keerthi Talari - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Methadone hydrochloride

Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized CT Screening Tool

Ismail Sari - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Inflammatory bowel disease

N/A

Need for Optimization of Immunization Coverage in Rheumatoid Arthritis

Maria Bazan Bardales - Canadian Rheumatology Association (CRA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Filters

28841 Abstracts